RCKTW Rocket Pharmaceuticals, Inc. Wa
$0.00▲ +1900.00%
Unknown
Other
Volume 2.78M
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
0.00 - 0.01
% vs 50 MA
-74.03%
% vs 200 MA
–%
RSI-14
46.7
MACD Histogram
+0.0000
Beta (1Y vs SPY)
5.24
Free Cash Flow
-$39.62M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$43.78M
COGS
–
Operating Exp
$46.92M
Operating Income
-$46.92M
EBIT
-$46.92M
Pretax Income
$131.84M
Net Income
$123.21M
Price & Volume History
Loading chart…
Recent News
Rocket Pharmaceuticals Shares Rise 8% After FDA Alignment on Danon Disease Trial
InvestorsHub · Sep 15, 2026 2:21 PM
Rocket Pharma Gets FDA Alignment On This Key Trial -- A Look At Some Key Highlights
Stocktwits · Sep 15, 2026 2:12 PM
Rocket Pharmaceuticals Says FDA Confirms Path to Complete Phase 2 Danon Disease Trial
MT Newswires · Sep 15, 2026 11:39 AM
Rocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease
Business Wire · Sep 15, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See RCKTW's money flow as a full page
Social Sentiment
No Reddit posts found for RCKTW.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.